Frequently Asked Questions
The market is segmented based on Global Chinese Hamster Ovary (CHO) Cells Market, By Type (Services and Product), System (Metabolic Selection System, Antibiotic Selection System and Others), Application (Biologics and Medical Research), End User (Biopharmaceutical Companies, Biotechnology Companies, Clinical Development and Manufacturing Organizations, Clinical Research Organizations, Academic Institutes and Research Organizations, Others), Distribution Channel (Direct Tenders, Retail Sales and Others) – Industry Trends and Forecast to 2031.
.
The Global Chinese Hamster Ovary Cells Cho Market size was valued at USD 384141.81 USD Thousand in 2023.
The Global Chinese Hamster Ovary Cells Cho Market is projected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2031.
The major players operating in the market include Thermo Fisher Scientific , AcceGen, RayBiotech Life , CLS Cell Lines Service GmbH, BPS Bioscience , GenTarget , Merck KGaA, Promega Corporation, Abeomics, Applied Biological Materials , ATCC, Sartorius AG, Lonza, Horizon Discovery Ltd, Cytiva, GTP Bioways, Curia Global .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
